Results 281 to 290 of about 8,713,756 (356)

Early CD4+ T cell proliferation and chronic T cell engagement impact myeloma outcomes following T cell engager therapy. [PDF]

open access: yesJ Clin Invest
Duffy AM   +14 more
europepmc   +1 more source

Dual targeting of RET and SRC synergizes in RET fusion‐positive cancer cells

open access: yesMolecular Oncology, EarlyView.
Despite the strong activity of selective RET tyrosine kinase inhibitors (TKIs), resistance of RET fusion‐positive (RET+) lung cancer and thyroid cancer frequently occurs and is mainly driven by RET‐independent bypass mechanisms. Son et al. show that SRC TKIs significantly inhibit PAK and AKT survival signaling and enhance the efficacy of RET TKIs in ...
Juhyeon Son   +13 more
wiley   +1 more source

Editorial: Enhancing CAR T-cell therapy with imaging. [PDF]

open access: yesFront Immunol
Lopci E, de Jong D, Dercle L.
europepmc   +1 more source

CD3 aptamers promote expansion and persistence of tumor-reactive T cells for adoptive T cell therapy in cancer

open access: gold
Ashwathi Puravankara Menon   +14 more
openalex   +1 more source

Acquisition of an immunosuppressive microenvironment after anti-CD19 CAR T-cell therapy is associated with T-cell dysfunction and resistance. [PDF]

open access: yesJ Immunother Cancer
Ponzo M   +23 more
europepmc   +1 more source

Proteasome: Role in T Cell Function Regulation. [PDF]

open access: yesInt J Biol Sci
Tang D, Wu X, Lei JH, Qiao Y, Deng CX.
europepmc   +1 more source

Home - About - Disclaimer - Privacy